How antiviral drugs block flu virus
February 4th, 2010 - 1:50 pm ICT by ANILondon, Feb 4 (ANI): Scientists at Iowa State University have identified the mechanism through which antiviral drugs block influenza A.
The study showed that these drugs block influenza A viruses from reproducing and spreading by attaching to a site within a proton channel necessary for the virus to infect healthy cells.
Previous studies have shown that antiviral drug amantadine binds to a flu virus and stops it from infecting a healthy cell. A paper based on X-ray studies concluded the drug attached to the lumen of the proton channel, the area inside the channel, and stopped the virus by blocking the channel.
Another study showed the drug attached to the surface of the virus protein near the proton channel and stopped the virus by indirectly changing the channel structure.
The new study led by Mei Hong showed that when amantadine is present at the pharmacologically relevant amount of one molecule per channel, it attaches to the lumen inside the proton channel.
Moreover, when there are high concentrations of amantadine in the membrane, the drug will also attach to a second site on the surface of the virus protein near the channel.
The virus begins an infection by attaching itself to a healthy cell. The healthy cell surrounds the flu virus and takes it inside the cell through a process called endocytosis. The virus then uses a protein called M2 to open a channel to the healthy cell.
Protons from the healthy cell flow through the channel into the virus and raise its acidity. That triggers the release of the virus’ genetic material into the healthy cell. The virus hijacks the healthy cell’s resources and uses them to reproduce and spread.
When amantadine binds to and blocks the M2 proton channel, the process doesn’t work and a virus can’t infect a cell and spread.
“Our study using solid-state nuclear magnetic resonance (NMR) technology unequivocally shows that the true binding site is in the channel lumen, while the surface-binding site is occupied only by excess drug,” Nature magazine quoted Hong as saying.
“The previous solution NMR study used 200-fold excess drug, which explains their observation of the surface-binding site. The resolution of this controversy means that medical chemists can now try to design new drugs to target the true binding site of the channel,” Hong added. (ANI)
- Understanding efficacy of current drugs and paving way for new ones - Oct 22, 2010
- Discovery suggests new way to prevent HIV from infecting human cells - Dec 23, 2010
- Molecular changes that helped Tamiflu resistance explained - Jun 04, 2010
- Cellular protein that acts as receptor for Ebola virus identified - May 03, 2011
- Anti-tumor drug that also fights flu virus - Mar 01, 2011
- Scientists use artificial, cell-like 'honey pots' to lure, trap deadly viruses - Mar 03, 2011
- Non-stick protein coating in semen cuts HIV infection - Sep 24, 2010
- Early warning alerts our cells against invading bugs - Oct 16, 2011
- Measles virus is 'the latest weapon against cancer' - Jan 13, 2011
- H1N1 used new trick to cause pandemic - Aug 06, 2010
- Molecule engineered to attack HIV shows positive results - Jan 20, 2011
- Japanese discovery could help fight resistant flu virus - Jul 16, 2009
- Widely used HIV drug could help prevent cervical cancer - May 04, 2011
- Human protein that prevents H1N1 influenza infection found - Dec 18, 2009
- How HIV infection kills T cells - Nov 25, 2010
Tags: acidity, amantadine, antiviral drug, antiviral drugs, binding site, channel structure, flu virus, genetic material, influenza, iowa state university, london feb, lumen, mei hong, nmr technology, nuclear magnetic resonance, proton channel, protons, solid state, virus protein, x ray